Cite

HARVARD Citation

    Saffo, S. et al. (2018). SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascites. Clinical liver disease. 11 (6), pp. 141-144. [Online]. 
  
Back to record